Biomarker auf der Intensivstation

Bei Biomarkern handelt es sich um Merkmale, die objektiv gemessen und als Indikatoren für normale biologische Prozesse, pathologische Prozesse oder pharmakologische Reaktionen auf eine therapeutische Intervention bewertet werden. Ihnen kommt eine große Bedeutung bei der Erkennung von Krankheiten und bei der Überwachung des Gesundheitsstatus zu.

Schlüsselwörter

Biomarker - Intensivmedizin - Screening - Diagnostik - Therapiesteuerung

• Literatur

• 1 Biomarkers Definitions Working G. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95 doi:10.1067/mcp.2001.113989
• 2 Povoa P, Salluh JIF, Lisboa T. Biomarkers in the ICU: less is more? Not sure. Intensive Care Med 2020;
• 3 Möckel M. Welche Bedeutung haben Biomarker auf der Intensivstation?. Med Klin Intensivmed Notfmed 2019; 114: 284-285 doi:10.1007/s00063-019-0573-8
• 4 Vafaie M, Stoyanov KM, Katus HA. et al. Kardiales Troponin und mehr beim akuten Koronarsyndrom. Internist 2019; 60: 555-563 doi:10.1007/s00108-019-0611-x
• 5 Möckel M. Biomarker in der Diagnostik kardiovaskulärer Notfälle. Internist 2019; 60: 564-570 doi:10.1007/s00108-019-0620-9
• 6 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062 doi:10.1016/S0140-6736(20)30566-3
• 7 Riedlinger D, Mockel M, Muller C. et al. High-sensitivity cardiac troponin T for diagnosis of NSTEMI in the elderly emergency department patient: a clinical cohort study. Biomarkers 2018; 23: 551-557 doi:10.1080/1354750X.2018.1460763
• 8 Singh H, Ramai D, Patel H. et al. B-Type Natriuretic Peptide: A Predictor for Mortality, Intensive Care Unit Length of Stay, and Hospital Length of Stay in Patients With Resolving Sepsis. Cardiol Res 2017; 8: 271-275 doi:10.14740/cr605w
• 9 Mehta C, Dara B, Mehta Y. et al. Retrospective study on prognostic importance of serum procalcitonin and amino-terminal pro-brain natriuretic peptide levels as compared to Acute Physiology and Chronic Health Evaluation IV Score on Intensive Care Unit admission, in a mixed Intensive Care Unit population. Ann Card Anaesth 2016; 19: 256-262 doi:10.4103/0971-9784.179616
• 10 Mockel M, von Haehling S, Vollert JO. et al. Early identification of acute heart failure at the time of presentation: do natriuretic peptides make the difference?. ESC Heart Fail 2018; 5: 309-315 doi:10.1002/ehf2.12290
• 11 Hilbert P, Zur Nieden K, Stuttmann R. D-Dimer-Screening bei chirurgischen Langzeitintensivpatienten. Anaesthesist 2005; 54: 210-214 doi:10.1007/s00101-004-0799-5
• 12 Hajsadeghi S, Kerman SR, Khojandi M. et al. Accuracy of D-dimer: fibrinogen ratio to diagnose pulmonary thromboembolism in patients admitted to intensive care units. Cardiovasc J Afr 2012; 23: 446-456 doi:10.5830/CVJA-2012-041
• 13 Konstantinides SV, Meyer G, Becattini C. et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41: 543-603 doi:10.1093/eurheartj/ehz405
• 14 Spring JL, Winkler A, Levy JH. The influence of various patient characteristics on D-dimer concentration in critically ill patients and its role as a prognostic indicator in the intensive care unit setting. Clin Lab Med 2014; 34: 675-686 doi:10.1016/j.cll.2014.06.015
• 15 Giannitsis E, Mair J, Christersson C. et al. How to use D-dimer in acute cardiovascular care. Eur Heart J Acute Cardiovasc Care 2017; 6: 69-80 doi:10.1177/2048872615610870
• 16 Chen S, Zhang D, Zheng T. et al. DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis 2020;
• 17 Knebel F. Moderne Bildgebung als „Biomarker“: kein Patient ohne Echokardiographie?. Med Klin Intensivmed Notfmed 2019; 114: 297-301 doi:10.1007/s00063-019-0568-5
• 18 Oppert M. Sepsisdiagnostik und Antibiotikasteuerung. Med Klin Intensivmed Notfmed 2019; 114: 286-289 doi:10.1007/s00063-019-0570-y
• 19 Djuma J, Kalenga P, Kazadi C. et al. Appréciation de la sévérité de lʼaffection des patients admis en réanimation par la mesure de la CRP. Pan Afr Med J 2015; 20: 401 doi:10.11604/pamj.2015.20.401.4311
• 20 Chen W, Zheng KI, Liu S. et al. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob 2020; 19: 18 doi:10.1186/s12941-020-00362-2
• 21 Kappert K, Jahic A, Tauber R. Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers 2020; 25: 616-625 doi:10.1080/1354750X.2020.1797880
• 22 Schuetz P, Beishuizen A, Broyles M. et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med 2019; 57: 1308-1318 doi:10.1515/cclm-2018-1181
• 23 Kip MM, Kusters R, MJ IJ. et al. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis. J Med Econ 2015; 18: 944-953 doi:10.3111/13696998.2015.1064934
• 24 Storm C. Biomarker nach Reanimation. Relevanz im klinischen Alltag für Prognoseeinschätzung und Therapiezieldefinition. Med Klin Intensivmed Notfmed 2019; 114: 313-318 doi:10.1007/s00063-019-0571-x
• 25 Braga F, Ferraro S, Mozzi R. et al. Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase. Clin Biochem 2013; 46: 148-151 doi:10.1016/j.clinbiochem.2012.09.005
• 26 Simetic L, Blazicevic K, Medugorac K. et al. Relative Change in S100 as a Biomarker of Survival in Patients With Metastatic Melanoma Treated With Pembrolizumab. Anticancer Res 2020; 40: 2157-2163 doi:10.21873/anticanres.14175
• 27 Hackl G. Akute Intoxikationen: Marker für Screening, Diagnose und Therapiesteuerung. Med Klin Intensivmed Notfmed 2019; 114: 302-312 doi:10.1007/s00063-019-0566-7
• 28 Steindl D, Boehmerle W, Körner R. et al. Novichok nerve agent poisoning. Lancet 2020;
• 29 Dear JW, Clarke JI, Francis B. et al. Risk stratification after paracetamol overdose using mechanistic biomarkers: results from two prospective cohort studies. Lancet Gastroenterol Hepatol 2018; 3: 104-113 doi:10.1016/S2468-1253(17)30266-2
• 30 Strimbu K, Tavel JA. What are biomarkers?. Curr Opin HIV AIDS 2010; 5: 463-466 doi:10.1097/COH.0b013e32833ed177